Your browser doesn't support javascript.
loading
The impact of HMG-CoA reductase inhibitors use on the clinical outcomes in critically ill patients with COVID-19: A multicenter, cohort study.
Al Sulaiman, Khalid; Aljuhani, Ohoud; Korayem, Ghazwa B; Altebainawi, Ali F; Al Harbi, Shmeylan; Al Shaya, Abdulrahman; Badreldin, Hisham A; Kensara, Raed; Alharthi, Abdullah F; Alghamdi, Jahad; Alawad, Ahad; Alotaibi, Rand; Kharbosh, Abdullah; Al Muqati, Hessa; Alhuwahmel, Abdulmohsen; Almusallam, Mohammed; Albarrak, Ghada; Al Sulaihim, Ibrahim; Alanazi, Bader; Al-Dosari, Bodoor S; Vishwakarma, Ramesh; Alsaeedi, Alawi S; Al Ghamdi, Ghassan; Alkofide, Hadeel; Al-Dorzi, Hasan M.
Afiliación
  • Al Sulaiman K; Pharmaceutical Care Department, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
  • Aljuhani O; College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
  • Korayem GB; King Abdullah International Medical Research Center-King Saud Bin Abdulaziz University for Health Sciences, Ministry of National Guard-Health Affairs, Riyadh, Saudi Arabia.
  • Altebainawi AF; Saudi Critical Care Pharmacy Research (SCAPE) Platform, Riyadh, Saudi Arabia.
  • Al Harbi S; Department of Pharmacy Practice, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia.
  • Al Shaya A; Department of Pharmacy Practice, College of Pharmacy, Princess Nourah Bint Abdulrahman University, Riyadh, Saudi Arabia.
  • Badreldin HA; Pharmaceutical Care Services, King Salman Specialist Hospital, Hail Health Cluster, Hail, Saudi Arabia.
  • Kensara R; Pharmaceutical Care Department, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
  • Alharthi AF; College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
  • Alghamdi J; King Abdullah International Medical Research Center-King Saud Bin Abdulaziz University for Health Sciences, Ministry of National Guard-Health Affairs, Riyadh, Saudi Arabia.
  • Alawad A; Pharmaceutical Care Department, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
  • Alotaibi R; College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
  • Kharbosh A; King Abdullah International Medical Research Center-King Saud Bin Abdulaziz University for Health Sciences, Ministry of National Guard-Health Affairs, Riyadh, Saudi Arabia.
  • Al Muqati H; Pharmaceutical Care Department, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
  • Alhuwahmel A; College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
  • Almusallam M; King Abdullah International Medical Research Center-King Saud Bin Abdulaziz University for Health Sciences, Ministry of National Guard-Health Affairs, Riyadh, Saudi Arabia.
  • Albarrak G; Pharmaceutical Care Department, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
  • Al Sulaihim I; King Abdullah International Medical Research Center-King Saud Bin Abdulaziz University for Health Sciences, Ministry of National Guard-Health Affairs, Riyadh, Saudi Arabia.
  • Alanazi B; Pharmaceutical Care Department, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
  • Al-Dosari BS; King Abdullah International Medical Research Center-King Saud Bin Abdulaziz University for Health Sciences, Ministry of National Guard-Health Affairs, Riyadh, Saudi Arabia.
  • Vishwakarma R; King Abdullah International Medical Research Center-King Saud Bin Abdulaziz University for Health Sciences, Ministry of National Guard-Health Affairs, Riyadh, Saudi Arabia.
  • Alsaeedi AS; Department of Pharmacy Practice, College of Pharmacy, Princess Nourah Bint Abdulrahman University, Riyadh, Saudi Arabia.
  • Al Ghamdi G; Department of Pharmacy Practice, College of Pharmacy, Princess Nourah Bint Abdulrahman University, Riyadh, Saudi Arabia.
  • Alkofide H; Clinical Pharmacy Department, Pharmacy College, Taif University, Taif, Saudi Arabia.
  • Al-Dorzi HM; Pharmaceutical Care Department, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
Front Public Health ; 10: 877944, 2022.
Article en En | MEDLINE | ID: mdl-36033795
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inhibidores de Hidroximetilglutaril-CoA Reductasas / COVID-19 Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Adult / Humans Idioma: En Revista: Front Public Health Año: 2022 Tipo del documento: Article País de afiliación: Arabia Saudita Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inhibidores de Hidroximetilglutaril-CoA Reductasas / COVID-19 Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Adult / Humans Idioma: En Revista: Front Public Health Año: 2022 Tipo del documento: Article País de afiliación: Arabia Saudita Pais de publicación: Suiza